What if GLP‑1s could change what you lose—not just how much? In a new 12‑week study, Omada demonstrated that members taking GLP-1s in the GLP-1 Care Track lost, on average, significantly more weight and body fat percentage than those on GLP‑1s alone, while preserving comparable muscle mass. Not only are they improving their body composition, Omada members also reported greater improvements in mood, anxiety symptoms, overall well‑being, physical functioning, and confidence in their ability to lose weight. Omada’s program delivers high-quality weight loss and supports both better body composition and an increase in quality of life. Learn more in the latest press release: https://lnkd.in/dUUrZQq9
Omada has supported 150,000 GLP-1 member journeys and counting. Why is this important? Through this experience, we’ve learned that combining GLP-1 treatment with a clinically-validated approach to lifestyle support is an essential part of sustained health outcomes. That’s why we’ve expanded our platform to include guided medication care—Omada’s new GLP-1 prescribing capability. With guided medication care: Members have a seamless experience from enrollment to first prescription, including an on-demand or scheduled video provider visit Proactive, individualized clinical support is available even after the visit ends, with lifestyle coaching, nutrition, activity, education, and side effect support. Payers and employers can ensure appropriate medication use while managing costs effectively Learn more: https://lnkd.in/ePVeZQsK
In weight health, the real question isn’t “how many pounds did you lose?”—it should be “what kind of pounds did you lose?” In a new 12‑week comparative study, those in Omada’s GLP‑1 Care Track, on average, lost 1.8x more total weight and 2.1x more body fat than a similar control group who didn’t have access to Omada’s program. Omada members also reported improvements in depressive and anxiety symptoms—important factors of long‑term success. 🔍 The findings point to a care model where GLP‑1s are combined with targeted strength training and behavior support to preserve muscle mass during rapid weight loss, while also improving physical function and overall well-being. Learn more: https://lnkd.in/dUUrZQq9
Clinical rigor is what turns Omada from “another vendor” into infrastructure for cardiometabolic care. OmadaSpark — an AI-powered tool built with Llama models on Amazon SageMaker AI — doesn’t replace care teams; it amplifies them, delivering evidence-based nutrition education and motivational interviewing between visits. Members who use OmadaSpark are 3x more likely to return to the app. Learn how we built it with AWS AI and AI at Meta: https://lnkd.in/di4uSZr6
The GLP-1 landscape just changed again. The FDA recently approved Eli Lilly and Company's Foundayo™ (orforglipron), joining Novo Nordisk's oral Wegovy® as the newest oral options in a rapidly expanding category. In our latest edition of Proof Points, Endocrinologist and Obesity Medicine Specialist, Rajiv R. breaks down the clinical differences between oral and injectable GLP-1s and how the growing range of options is re-shaping obesity care. Read it here ↓
Thank you to Northeast Business Group on Health for inviting us to be a sponsor at: Cardiometabolic Health as a Business Imperative Conference and featuring our CMO Thomas Tsang, MD, MPH to speak. Dr. Tsang took part in a timely panel discussion (Breaking Down the Silos: Heart, Obesity & Diabetes) with other leading industry figures, including Emmanuelle Clerisme-Beaty, MD and Cara Pensabene, MD. Dr. Tsang’s participation on this panel was noteworthy, as Omada’s perspective on population-level virtual care solutions for heart health, obesity and diabetes is unique in the market. With the recent addition of Omada for Cholesterol, Omada’s suite of program offerings now covers all three chronic conditions spotlighted during the panel discussion. We value these exciting opportunities to represent Omada during important conversations about how benefits leaders are shaping the future of healthcare. See you at the next conference!
The latest Omada platform expansion is here: GLP-1 guided medication care. We’re adding GLP-1 prescribing to our proven behavior change platform, helping members experience not only the strong start these medications can provide, but a prescription that works hand in hand with an entire ecosystem of care. That ecosystem already features a dedicated health coach, education, digital tools and tailored support that can include cardiometabolic specialists, an exercise specialist and more. Our GLP-1 guided medication care expands this by including prescribing and medication management from licensed providers trained in obesity treatment. Read more: https://buff.ly/dMBVG3c
Behavior change doesn’t happen in a single visit — and it rarely happens in a straight line. Here’s what adaptive care looks like in everyday life: adjusting goals as circumstances change, using technology to make food choices easier, and turning data into actionable insights. This is compassionate intelligence in action: human coaching, powered by insights, to bend the curve of chronic disease Learn more: https://lnkd.in/d6qDdGwb
We’ve expanded Omada’s cardiometabolic platform with Omada for Cholesterol, so one program can support obesity, diabetes, hypertension, cholesterol, and GLP‑1 use. Omada for Cholesterol provides members with: 💡Tailored cholesterol support and goal‑setting from a dedicated care team cardiometabolic specialists 💡 A heart‑healthy community for accountability and momentum 💡Integrated behavior change tools and medication adherence support For employers and health plans, that means a single, integrated partner for highly prevalent conditions — and a strategy that reflects how cardiovascular risk really accumulates, across multiple comorbidities over time. Learn more: https://lnkd.in/eqjgs-ir
GLP-1s are dramatically changing obesity treatment. But how can we help optimize the investment — for employers and for the people who need them? Omada’s answer: GLP-1 guided medication care. We’re expanding our platform to include GLP-1 prescribing, so from the very start of a GLP-1 prescription, our members have a continuous, tailored experience that includes prescriber, coach, and behavioral and lifestyle support guiding the way. The goal: make every prescription an investment in company and workforce health. Learn more: https://lnkd.in/dWivJ4yT
